Hyloris Pharmaceuticals: Information on the total number of voting rights and shares – additional thresholds
30 juin 2020 03h00 HE
|
Hyloris Pharmaceuticals
RESS RELEASE Information on the total number of voting rights and shares – additional thresholds Liège (Belgium), 30 June 2020, 9h00 (CEST) – regulated information – In accordance with article 15 of...
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
26 juin 2020 12h41 HE
|
Hyloris Pharmaceuticals
This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the Offered Shares involves substantial risks and uncertainties....
Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
24 juin 2020 01h00 HE
|
Hyloris Pharmaceuticals
This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the Offered Shares involves substantial risks and uncertainties....
Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option and Over-Allotment, at the Midpoint of the Price Range of its Initial Public Offering on Euronext Brussels
19 juin 2020 12h10 HE
|
Hyloris Pharmaceuticals
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an...
Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of its Initial Public Offering on Euronext Brussels
18 juin 2020 11h03 HE
|
Hyloris Pharmaceuticals
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an offer to...
Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
17 juin 2020 01h00 HE
|
Hyloris Pharmaceuticals
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an offer to...
Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels
03 juin 2020 01h00 HE
|
Hyloris Pharmaceuticals
This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the offered shares involves substantial risks and uncertainties....
Hyloris appoints Patrick Jeanmart as Chief Financial Officer
26 mai 2020 01h00 HE
|
Hyloris Pharmaceuticals
Hyloris Pharmaceuticals SA (“Hyloris” or the “Company”) Hyloris appoints Patrick Jeanmart as Chief Financial Officer Liège, Belgium – 26 May 2020: Hyloris Pharmaceuticals SA, an innovative...
Hyloris Pharmaceuticals successfully raises €15 million in funding round
30 avr. 2020 10h00 HE
|
Hyloris Pharmaceuticals
Hyloris Pharmaceuticals SA (“Hyloris” or the “Company”) Hyloris Pharmaceuticals successfully raises €15 million in funding round Liège, Belgium, – 30 April 2020: Hyloris Pharmaceuticals SA, an...